Pseudomonas septicaemia associated with HIV

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• HIV/AIDS Research

Background:

• Pseudomonas bloodstream infections (BSI) are a serious concern in immunocompromised patients.
• Patients with Acquired Immunodeficiency Syndrome (AIDS) are at increased risk for opportunistic infections.
• Central venous catheters (CVCs) are common in managing AIDS patients but can be a source of infection.

Purpose of the Study:

• To investigate the incidence and risk factors of Pseudomonas scepticaemia in patients with AIDS.
• To identify outcomes and mortality associated with Pseudomonas BSI in this population.
• To explore the role of co-infections and CVCs in Pseudomonas scepticaemia among AIDS patients.

Main Methods:

• Retrospective analysis of 584 patients with AIDS from July 1985 to January 1990.
• Identification of Pseudomonas scepticaemia cases and associated clinical data.
• Statistical analysis to determine risk factors and mortality predictors.

Main Results:

• 19 out of 584 AIDS patients developed Pseudomonas scepticaemia.
• 10 patients had concurrent cytomegalovirus infection.
• 14 patients had a CVC in situ; 11 infections originated from the CVC.
• 7 patients died, with higher mortality in non-CVC-related infections and when CVCs were not removed.

Conclusions:

• Pseudomonas scepticaemia is a significant complication in AIDS patients, particularly those with CVCs or cytomegalovirus co-infection.
• Source of infection and CVC management are critical factors influencing mortality.
• Prompt removal of infected CVCs and management of co-infections are crucial for improving outcomes.